106 related articles for article (PubMed ID: 3004721)
1. Anomalous adenosine cyclic 3':5'-monophosphate responses to glucagon in patients with hepatocellular carcinoma.
Pun KK; Ho PW; Yeung RT
Cancer Res; 1986 Apr; 46(4 Pt 2):2152-4. PubMed ID: 3004721
[TBL] [Abstract][Full Text] [Related]
2. Glucagon and prostaglandin E1 stimulation of cyclic adenosine 3', 5'-monophosphate levels and adenylate cyclase activity in benign hyperplastic nodules and malignant hepatomas of ethionine-treated rats.
Chayoth R; Epstein SM; Field JB
Cancer Res; 1973 Aug; 33(8):1970-4. PubMed ID: 4352743
[No Abstract] [Full Text] [Related]
3. Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
Pun KK; Yeung CK; Ho PW; Lin HJ; Chan MK; Yeung RT
Clin Nephrol; 1984 Apr; 21(4):235-40. PubMed ID: 6329569
[TBL] [Abstract][Full Text] [Related]
4. The role of glucagon administration in the diagnosis and treatment of patients with tumor hypoglycemia.
Hoff AO; Vassilopoulou-Sellin R
Cancer; 1998 Apr; 82(8):1585-92. PubMed ID: 9554538
[TBL] [Abstract][Full Text] [Related]
5. [The cyclic AMP, insulin and glucose responses to glucagon stimulation in patients with liver cirrhosis according to the stage of development ].
Esteva Díaz F; Ducóns García J; Ceña Lázaro G; Márquez Galván M; Juste Rullo G; Barrao Comps F
Rev Clin Esp; 1986 Nov; 179(7):347-51. PubMed ID: 3025944
[No Abstract] [Full Text] [Related]
6. Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma.
Sudilovsky O; Gunter R
Cancer Res; 1975 Apr; 35(4):1069-74. PubMed ID: 234792
[TBL] [Abstract][Full Text] [Related]
7. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
Pun KK; Young RT; Wang C; Tam CF; Ho PW
J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucagon-stimulated glucose output in livers of acutely uremic rats.
Perez GO; Rabinovitch A; Rietberg B; Owens B; Schiff ER
J Lab Clin Med; 1982 May; 99(5):669-77. PubMed ID: 6279748
[TBL] [Abstract][Full Text] [Related]
9. [Effects of intravenous perfusion of glucagon on plasma concentrations of glucose, insulin and cyclic AMP in patients with hepatic cirrhosis].
Conde Yagüe R; Gutiérrez-Cortines Corral MD; Ledesma Castaño F; González Coterillo T; Valle Cagigas M; González Puerta C
Rev Clin Esp; 1985 Oct; 177(5):209-11. PubMed ID: 3001846
[No Abstract] [Full Text] [Related]
10. Endocrine control of cyclic adenosine 3',5'-monophosphate levels in several Morris hepatomas.
Butcher FR; Scott DF; Potter VR; Morris HP
Cancer Res; 1972 Oct; 32(10):2135-40. PubMed ID: 4343008
[No Abstract] [Full Text] [Related]
11. Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart.
Clark CM; Beatty B; Allen DO
J Clin Invest; 1973 May; 52(5):1018-25. PubMed ID: 4349483
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-induced alterations of plasma levels of cyclic AMP and glucose in patients with liver disease.
Klotz U; Antonin KH
Z Gastroenterol; 1984 Mar; 22(3):147-52. PubMed ID: 6326401
[TBL] [Abstract][Full Text] [Related]
13. Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH). II. Modification of cyclic adenosine-3',5'-monophosphate levels by catecholamines, glucagon and Vinca alkaloids in normal chicken liver and VTH.
Gyapay G; Lapis E; Jeney A; Lapis K
Acta Biol Hung; 1984; 35(1):35-41. PubMed ID: 6095566
[TBL] [Abstract][Full Text] [Related]
14. Hypoglycemia and hypoinsulinemia associated with hepatoma in a dog.
Strombeck DR; Krum S; Meyer D; Kappesser RM
J Am Vet Med Assoc; 1976 Oct; 169(8):811-2. PubMed ID: 185183
[No Abstract] [Full Text] [Related]
15. [The effect of thyroid function on the increase of plasma cyclic AMP following glucagon injection (author's transl)].
Jäckel W; Heimes J; Herrmann J
J Clin Chem Clin Biochem; 1980 Dec; 18(12):909-15. PubMed ID: 6259272
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis.
Francavilla A; Jones AF; Starzl TE
Gastroenterology; 1978 Dec; 75(6):1026-32. PubMed ID: 213345
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-stimulated but not isoproterenol-stimulated glucose formation inhibition by interleukin-6 in primary cultured rat hepatocytes.
Quaas M; Stümpel F; Christ B
Horm Metab Res; 2005 Nov; 37(11):666-71. PubMed ID: 16308834
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal regulation of carbohydrate metabolism in the liver in plague intoxication].
Cherkasova TD; Iurkiv VA
Biokhimiia; 1994 Mar; 59(3):457-61. PubMed ID: 8180275
[TBL] [Abstract][Full Text] [Related]
19. The breakdown of glycogen in the lysosomes of newborn rat hepatocytes: the effects of glucose, cyclic 3',5'-AMP and caffeine.
Kalamidas SA; Kotoulas OB; Kotoulas AO; Maintas DB
Histol Histopathol; 1994 Oct; 9(4):691-8. PubMed ID: 7894141
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
